Decoding the Diabetes-Induced Inflammatory Chessboard: ASC Inhibition Emerges as a Potential Key to Combat Atherosclerosis
Recent research conducted by ZyVersa Therapeutics has shed light on the significant role of AIM2 and NLRP3 inflammasomes in promoting the development of atherosclerosis, specifically in diabetic mice. This groundbreakin...
Dec 6, 2023
Clinical Study
Atherosclerosis
